))
Soul Stories- Hector Romero
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on May 30, 2024 01:33 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 300944926 series 2846221
Content provided by Dr. Gayle M. Randall. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Gayle M. Randall or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Tune in to Dr Randall and Hector Romero of Sanesco on Soul Stories Season 2.
A natural-born leader and savvy businessman, Romero built Sanesco from the ground up with the vision of improving global healthcare and optimizing clinical outcomes for individuals and families worldwide.
Hector Romero was instrumental in bringing the first-ever urinary neurotransmitter test for clinical use in the United States and founded the first company in the world to offer a complete clinical model specialized in arming physicians with non-invasive laboratory testing for neurotransmitters and non-drug treatments to rebuild neurotransmitters naturally within the body. He was specifically interested the patient-driven demand for natural options and the growing need for healthcare practitioners to identify the underlying root causes of their patients’ symptoms and conditions aside from treating or masking symptoms solely with pharmaceuticals.
A native of Venezuela, Romero planted roots in Western North Carolina over 16 years ago with his wife and son as he accepted a position as Director of International Business Development at Great Smokies Laboratories (now Genova Diagnostics). His passion for furthering the knowledge and understanding of the body’s communication system and his determination the address the underlying root causes of chronic symptoms and conditions, such as depression, anxiety, insomnia, ADD/ADHD among many others related to neurotransmitter and hormone imbalances, led to the incorporation of Sanesco International, Inc. in December of 2004.
For nearly a decade, Sanesco has specialized in furthering the knowledge and understanding of the HPA Axis (Hypothalamic-Pituitary-Adrenal Axis) and improving patient quality of life worldwide. By developing innovative clinical tools for clinicians to improve patient outcomes, Sanesco has emerged as a leader in assessing, monitoring and correcting neurotransmitter and hormone imbalances. Hundreds of clinicians and more than 120,000 patients worldwide have reaped the benefits of Sanesco’s Communication System Management™.
Don't miss this intriguing episode only on Soul Stories.
79 episodes
Share
